<p>The World Health Organization (WHO) said Wednesday its experts were still reviewing safety data on the AstraZeneca Covid-19 vaccine following concerns around blood clots but recommended that vaccination programmes continue.</p>.<p>"The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data," the UN health agency said in a statement.</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/international/blood-clots-in-astrazeneca-jab-very-rare-who-official-963116.html" target="_blank">Blood clots in AstraZeneca jab very rare: WHO official</a></strong></p>.<p>"At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue."</p>
<p>The World Health Organization (WHO) said Wednesday its experts were still reviewing safety data on the AstraZeneca Covid-19 vaccine following concerns around blood clots but recommended that vaccination programmes continue.</p>.<p>"The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data," the UN health agency said in a statement.</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/international/blood-clots-in-astrazeneca-jab-very-rare-who-official-963116.html" target="_blank">Blood clots in AstraZeneca jab very rare: WHO official</a></strong></p>.<p>"At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue."</p>